Top Biologics Companies in India - India's Leading Innovators in Biologics

Lakshita Verified

Content Analyst   |   Updated 2026-06-19

Reviewed by ViewGates Editorial Team

India has quietly become one of the most important biologics markets in the world. From biosimilars to monoclonal antibodies, Indian companies are not just manufacturing for domestic demand — they are supplying hospitals and patients across the US, Europe, and emerging markets. Serum Institute of India, Biocon Limited, Dr. Reddy’s laboratories rank among the top biologics companies in India. If you are a healthcare buyer, investor, or simply someone trying to understand who is driving this space, here is a clear-eyed look at the companies that matter.

Comparing the Top 10 Biologics Brands in India

These ratings reflect ViewGates' independent expert evaluation across weighted factors (service quality, support, market presence). They are not user-submitted scores.

Detailed Profile of the Top 10 Biologic Companies in India

Here is the overview of the top biologic companies in India:

1. Serum Institute of India

Serum Institute of India develops and manufactures vaccines for a wide range of infectious diseases, supplying both domestic immunization programs and global public health initiatives. It produces vaccines for measles, polio, influenza, COVID-19, and other preventive therapies. The company plays a major role in supplying low-cost vaccines to government health systems and international organizations.

2. Biocon Limited

Biocon Limited is a biopharmaceutical company focused on biosimilars, biologics, and complex active pharmaceutical ingredients (APIs). It develops treatments for diabetes, oncology, immunology, and nephrology. The company serves regulated and emerging markets through vertically integrated research, development, and manufacturing capabilities.

3. Dr. Reddy's Laboratories

Dr. Reddy’s Laboratories is a pharmaceutical company engaged in the development, manufacturing, and commercialization of generic medicines, active pharmaceutical ingredients, and biosimilars. It operates across multiple therapeutic areas including gastroenterology, cardiovascular, oncology, and dermatology. The company serves both branded and generic markets, with significant presence in regulated regions.

4. Syngene International Ltd.

Syngene International provides contract research, development, and manufacturing services to pharmaceutical, biotechnology, and agrochemical companies. It supports drug discovery, preclinical research, clinical development, and commercial manufacturing. Customers include multinational pharmaceutical companies and biotech firms.

5. Bharat Biotech

Bharat Biotech is a biotechnology company focused on vaccine research, development, and manufacturing for infectious diseases and public health needs. It develops vaccines for diseases such as rotavirus, typhoid, rabies, and COVID-19. The company operates research-driven programs aimed at addressing unmet medical needs in emerging markets.

6. Biological E. Limited

Biological E. Limited is a pharmaceutical and vaccine manufacturer producing preventive vaccines and injectable formulations. It supplies immunization products for public health programs and essential medicines for healthcare systems. The company focuses on affordable vaccine production and global health partnerships.

7. Reliance Life Sciences

Reliance Life Sciences is a biotechnology company engaged in biopharmaceutical development, regenerative medicine, biosimilars, and clinical research services. It focuses on areas such as oncology, blood products, and stem cell research. The company operates within the broader Reliance Group ecosystem, supporting healthcare innovation and biologics development.

8. Panacea Biotec

Panacea Biotec is a pharmaceutical and biotechnology company engaged in vaccines, specialty pharmaceuticals, and oncology support products. It develops and manufactures preventive vaccines and therapeutic formulations for domestic and international markets. The company also provides healthcare solutions for public immunization programs.

9. Wockhardt Ltd.

Wockhardt Ltd. is a pharmaceutical company engaged in the development and manufacturing of formulations, injectables, and active pharmaceutical ingredients. It focuses on therapeutic areas such as antibiotics, cardiovascular treatments, and critical care medicines. The company serves hospital and retail pharmaceutical markets across multiple regions.

10. Laurus Bio

Laurus Bio is a biotechnology and biomanufacturing organization focused on recombinant proteins, biologics development support, and contract development and manufacturing services. It operates within the Laurus ecosystem, supporting biologics and advanced therapeutic production. The company serves pharmaceutical and biotechnology clients requiring scalable bioprocessing capabilities.

Key Evaluation Factors We Assess

This table highlights important factors that are used to evaluate top companies:

Why The Right Biologic Company is Key for Healthcare Sector

Biologics are a specific type of medicines that are derived from living cells such as vaccines, insulin, cancer therapies and autoimmune treatments. They are expensive to develop and complex to manufacture, which is precisely why India's combination of scientific talent and cost-efficient production has created such a strong competitive position. Biologics are not standard medicines. They are complex, temperature-sensitive, and derived from living systems — which means the company behind them matters as much as the molecule itself. A wrong choice here does not just affect cost. It can affect patient outcomes directly.

How to Choose the Right Biologic Company

Here are a few steps to notice while choosing the right biologic company:

• Check approvals: You should choose a company that has proper government and global health approvals.
• 
  Examine the safety record: Choose a company with a solid history of low risk and rigorous safety testing.
• 
  Quality of medicines: Prefer companies that are especially known for their consistent and high-quality biologic drugs.
• 
  Research and experience: Look for a company that has strong research work and years of experience.

Biologics Companies Trends in India: What You Should Know

Here are some major trends in Indian biologics companies:

Material Insights - Biologics companies manufacture biologics using living systems like cells and microorganisms, which makes raw material sourcing more complex than regular medicines. Most key inputs like culture media and purification resins are still imported, adding cost and supply risk. Indian companies are working on local alternatives, but full self-reliance is still some time away.

Demand Pattern - Domestically, growing cases of cancer, diabetes, and autoimmune diseases are pushing up hospital demand for biologics every year. At the same time, markets in the US and Europe are actively sourcing affordable biosimilars as patents on expensive branded drugs expire. Indian manufacturers are well-placed to serve both ends of this demand.

Pricing - Biologics are generally costlier than conventional drugs, but Indian biosimilars are making them far more accessible. A biosimilar of a cancer drug like trastuzumab can cost 60–70% less than the original branded version. Government price controls add further affordability for domestic patients, while Indian companies stay competitive in export markets through cost-saving manufacturing.

Biologics Types - In India, there are various types of biologics available, from biosimilar insulins to erythropoietins that have been made here for decades to monoclonal antibodies for cancer and autoimmune conditions. Vaccines remain a major category, with Serum Institute leading at a global scale. Newer areas like gene therapies and cell-based treatments are still in early-stage but gaining investment interest.

Sustainability - In the production of biologics, there is use of considerable water, energy, and single-use plastic components, making it resource-heavy by nature. Companies like Biocon have started putting sustainability measures in place, including water recycling and cleaner energy use at their facilities. Carbon reporting is still new to the sector in India but is becoming a baseline expectation from global partners and ESG-focused buyers.

Market Overview - India holds a strong position in the global biologics and biosimilars space. The development of industry is supported by improving regulatory standards and cost-competitive manufacturing. The CDSCO has updated its biosimilar guidelines as per international best practices, making it easier to get Indian products accepted in regulated markets.

How to get the service: Large hospitals and organizations usually avail the services through trusted manufacturers such as Biocon, Dr. Reddy’s or Bharat Biotech. Government hospitals and public health programs usually avail it from central agencies like Biocon limited or from tenders of state health departments.

How ViewGates evaluates and rates these companies

Our evaluations are conducted independently by the ViewGates Editorial & Research Team. To build a complete picture of each company, our analysts aggregate public sentiment and data from multiple external sources — including community and trade forums, survey data, verified reviews across the web, and direct industry inquiries — and combine this with our internal database and proprietary scoring criteria such as service quality, support, pricing, and overall market presence.

User sentiment is one input among many; final ratings reflect ViewGates' independent expert assessment and are not based on direct user submissions on this platform. We follow a structured, consistent methodology to ensure fair comparisons across companies. Learn more on our Methodology page. To suggest a correction, contact us at support@viewgates.com.